Steven A. Buckner

1.2k total citations
57 papers, 986 citations indexed

About

Steven A. Buckner is a scholar working on Molecular Biology, Urology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steven A. Buckner has authored 57 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 17 papers in Urology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steven A. Buckner's work include Urinary Bladder and Prostate Research (17 papers), Receptor Mechanisms and Signaling (16 papers) and Ion channel regulation and function (12 papers). Steven A. Buckner is often cited by papers focused on Urinary Bladder and Prostate Research (17 papers), Receptor Mechanisms and Signaling (16 papers) and Ion channel regulation and function (12 papers). Steven A. Buckner collaborates with scholars based in United States, United Kingdom and France. Steven A. Buckner's co-authors include Ivan Milicic, Murali Gopalakrishnan, A.V. Daza, Arthur A. Hancock, Michael J. Coghlan, Michael E. Brune, James P. Sullivan, William A. Carroll, Sheila M. Knepper and Kristi L. Whiteaker and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Steven A. Buckner

54 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven A. Buckner United States	19	434	335	251	154	112	57	986
Ivan Milicic United States	19	554 1.3×	310 0.9×	127 0.5×	151 1.0×	202 1.8×	42	1.1k
Michael E. Brune United States	18	251 0.6×	182 0.5×	157 0.6×	83 0.5×	80 0.7×	41	746
A.V. Daza United States	12	253 0.6×	188 0.6×	95 0.4×	170 1.1×	73 0.7×	22	658
Lisbeth Nilvebrant Sweden	16	362 0.8×	595 1.8×	104 0.4×	248 1.6×	91 0.8×	29	1.1k
Kristi L. Whiteaker United States	15	249 0.6×	95 0.3×	133 0.5×	142 0.9×	53 0.5×	21	584
R. Testa Italy	18	285 0.7×	251 0.7×	55 0.2×	200 1.3×	166 1.5×	49	908
James S. Polakowski United States	17	405 0.9×	35 0.1×	111 0.4×	147 1.0×	134 1.2×	39	900
Barry Kenny United Kingdom	12	595 1.4×	236 0.7×	62 0.2×	324 2.1×	154 1.4×	19	951
Rodolfo Testa Italy	15	280 0.6×	176 0.5×	64 0.3×	182 1.2×	117 1.0×	34	617
Bengt Sparf Sweden	13	291 0.7×	344 1.0×	73 0.3×	322 2.1×	80 0.7×	15	874

Countries citing papers authored by Steven A. Buckner

Since Specialization

Citations

This map shows the geographic impact of Steven A. Buckner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven A. Buckner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven A. Buckner more than expected).

Fields of papers citing papers by Steven A. Buckner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven A. Buckner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven A. Buckner. The network helps show where Steven A. Buckner may publish in the future.

Co-authorship network of co-authors of Steven A. Buckner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven A. Buckner. A scholar is included among the top collaborators of Steven A. Buckner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven A. Buckner. Steven A. Buckner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buckner, Steven A., et al.. (2014). A Review of Risk Analysis and Helicopter Air Ambulance Accidents. Air Medical Journal. 33(5). 218–221. 10 indexed citations

Milicic, Ivan, et al.. (2007). A‐272651, a nonpeptidic blocker of large‐conductance Ca²⁺‐activated K⁺channels, modulates bladder smooth muscle contractility and neuronal action potentials. British Journal of Pharmacology. 151(6). 798–806. 8 indexed citations

Buckner, Steven A., Kristi L. Whiteaker, Eduardo Molinari, et al.. (2007). Characterization of a novel ATP‐sensitive K ⁺ channel opener, A‐251179, on urinary bladder relaxation and cystometric parameters. British Journal of Pharmacology. 151(4). 467–475. 19 indexed citations

Milicic, Ivan, Steven A. Buckner, A.V. Daza, et al.. (2006). Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs. European Journal of Pharmacology. 532(1-2). 107–114. 14 indexed citations

Fryer, Ryan M., Lee C. Preusser, Michael E. Brune, et al.. (2005). Pharmacological Characterization of the Novel Dihydropyridine Potassium Channel Opener, (9R)-9-(3-Iodo-4-methylphenyl)-5,9-dihydro-3H-furo[3,4-b]pyrano[4,3-e]pyridine-1,8(4H,7H)-dione (A-325100), and the Regulation of Cardiovascular Function in Conscious and Anesthetized Beagle Dogs. Journal of Cardiovascular Pharmacology. 46(2). 232–240. 6 indexed citations

Malysz, John, Steven A. Buckner, A.V. Daza, et al.. (2004). Functional characterization of large conductance calcium-activated K + channel openers in bladder and vascular smooth muscle. Naunyn-Schmiedeberg s Archives of Pharmacology. 369(5). 481–489. 42 indexed citations

Turner, Sean, William A. Carroll, Murali Gopalakrishnan, et al.. (2003). The discovery of a new class of large-conductance Ca2+-activated K+ channel opener targeted for overactive bladder: synthesis and structure–activity relationships of 2-amino-4-azaindoles. Bioorganic & Medicinal Chemistry Letters. 13(12). 2003–2007. 18 indexed citations

Gopalakrishnan, Murali, Thomas R. Miller, Steven A. Buckner, et al.. (2003). Pharmacological characterization of a 1,4‐dihydropyridine analogue, 9‐(3,4‐dichlorophenyl)‐3,3,6,6‐tetramethyl‐3,4,6,7,9,10‐hexahydro‐1,8(2H,5H)‐acridinedione (A‐184209) as a novel K_ATP channel inhibitor. British Journal of Pharmacology. 138(2). 393–399. 9 indexed citations

Turner, Sean, William A. Carroll, Michael E. Brune, et al.. (2003). Structure–activity relationship of a novel class of naphthyl amide KATP channel openers. Bioorganic & Medicinal Chemistry Letters. 13(10). 1741–1744. 5 indexed citations

10.

Hancock, Arthur A., Steven A. Buckner, Michael E. Brune, et al.. (2002). Preclinical Pharmacology of Fiduxosin, a Novel α1-Adrenoceptor Antagonist with Uroselective Properties. Journal of Pharmacology and Experimental Therapeutics. 300(2). 478–486. 38 indexed citations

11.

Buckner, Steven A., Ivan Milicic, A.V. Daza, et al.. (2002). ABT-866, a novel α1A-adrenoceptor agonist with antagonist properties at the α1B- and α1D-adrenoceptor subtypes. European Journal of Pharmacology. 449(1-2). 159–165. 11 indexed citations

12.

Drizin, Irene, Mark W. Holladay, Sujatha M. Gopalakrishnan, et al.. (2002). Structure–Activity studies for a novel series of tricyclic dihydropyrimidines as KATP channel openers (KCOs). Bioorganic & Medicinal Chemistry Letters. 12(11). 1481–1484. 49 indexed citations

13.

Buckner, Steven A., Ivan Milicic, A.V. Daza, et al.. (2001). A-315456: a selective α1D-adrenoceptor antagonist with minimal dopamine D2 and 5-HT1A receptor affinity. European Journal of Pharmacology. 433(1). 123–127. 9 indexed citations

14.

Buckner, Steven A., Ivan Milicic, A.V. Daza, et al.. (2000). Pharmacological and molecular analysis of ATP-sensitive K+ channels in the pig and human detrusor. European Journal of Pharmacology. 400(2-3). 287–295. 64 indexed citations

15.

Buckner, Steven A., et al.. (1996). α1-Adrenoceptor-induced contractility in rat aorta is mediated by the α1D subtype. European Journal of Pharmacology. 297(3). 241–248. 114 indexed citations

16.

Brune, Michael E., et al.. (1996). Effects of Selective and Nonselective Alpha-1 -Adrenoceptor Antagonists on Intraurethral and Arterial Pressures in Intact Conscious Dogs. Pharmacology. 53(6). 356–368. 29 indexed citations

17.

Hancock, Arthur A., Steven A. Buckner, Robert B. Warner, et al.. (1994). Receptor Interactions of Abbott-81988, A Highly Potent, Non-Peptide Angiotensin-II Antagonist Selective for Type-1 Receptors. Journal of Receptor Research. 14(3-4). 229–249. 1 indexed citations

18.

Hancock, Arthur A., Steven A. Buckner, Robert B. Warner, et al.. (1993). Pharmacological characterization of abbott-81282, a novel, non-peptide angiotensin-II antagonist selective for type-1 receptors. Life Sciences. 53(11). 929–937. 2 indexed citations

19.

Winn, Martin, Biswanath De, Thomas M. Zydowsky, et al.. (1993). 2-(Alkylamino)nicotinic acid and analogs. Potent angiotensin II antagonists. Journal of Medicinal Chemistry. 36(18). 2676–2688. 18 indexed citations

20.

Bush, Eugene N., et al.. (1989). Novel Adrenergic Compounds. I. Receptor Interactions of ABBOTT-54741 [(5,6-Dihydroxy-l,2,3,4-Tetrahydro-l-Naphthtyl)Imidazoline], an α-Adrenergic Agonist. Journal of Cardiovascular Pharmacology. 13(3). 382–391.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact